Eleven Biotherapeutics is transforming protein drug discovery, expanding possibilities beyond traditional protein engineering. We create a new breed of proteins. Eleven is creating the next generation of engineered protein drugs that are purposefully designed and tuned to have unique therapeutic properties, while maintaining the optimal natural attributes of the protein.
Our platform unleashes innovative protein therapeutics. Eleven's industry-leading proprietary protein engineering platform enables the rapid, efficient and effective selection of all classes of protein drugs and can be applied to all therapeutic areas.
Our differentiated protein products are designed for superior therapeutic impact. Eleven has a proprietary pipeline in ocular disease comprising protein products that are engineered with unique properties to treat diseases in new and more effective ways.
